Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Materialise: 3 Key Takeaways for Long-Term Investors

Management is balancing higher R&D spending with disciplined cost control to fuel long-term growth across three divisions.

Materialise, a leader in 3D printing technology, reported steady financial performance on its third-quarter 2026 earnings call. The company reaffirmed its full-year revenue guidance of EUR 273 million to EUR 283 million, highlighting its focus on high-margin healthcare and specialized industrial markets. Materialise's medical division, which provides 3D-printed surgical guides and software, is driving growth due to increased demand for personalized medical solutions.

Meanwhile, the company's manufacturing division is shifting from prototyping to recurring production contracts, with series production revenues growing by over 30% year-over-year in the third quarter. The software division has successfully transitioned customers to recurring subscription licenses, with recurring revenue now representing 84% of the division's total revenue.

Materialise's strong financial position, including a net cash reserve of EUR 82.5 million, positions the company well for long-term expansion as it balances research investments with operational discipline.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fool.com →

More in Finance & Markets

More from Tuesday 17 November →